⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 3, 2024JAMA

Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine

Andrew H. Talal Marianthi Markatou Anran Liu Ponni Perumalswami Amreen Dinani Jonathan N. Tobin Lawrence S. Brown

View Full Paper

Ask AI

Bookmark

Share

Abstract

Facilitated telemedicine may promote hepatitis C virus elimination by mitigating geographic and temporal barriers.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Talal et al. (2024) studied this question.

synapsesocial.com/papers/68e7079eb6db643587681ebc https://doi.org/10.1001/jama.2024.2452

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study2024 · 9 citations
2Opioid treatment program-integrated facilitated telemedicine for hepatitis C treatment: a hybrid effectiveness-implementation analysis2025
3Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs2024 · 4 citations
4“I really can’t imagine anything that could’ve been more easy”: patient perspectives on low-threshold peer-facilitated telemedicine hepatitis C treatment for people who use drugsRCT · 2026
5Long‐Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response2025